Fundz

Avm Biotechnology, Llc reported raising $4.43 Million in an amended SEC Form D filing, from an offering of $14.7 Million

PRIVATEMay 03, 2021$4.4M of $14.7M raised

Amount Raised

$4.43 Million

$4.43 Million sold, per SEC Form D (first sale May 3, 2021)

Round Type

Seed

SeattleBiotechnology

Quick answer

AVM Biotechnology raised $4.43 Million in a Seed round, dated May 3, 2021. AVM Biotechnology is based in Seattle, Washington, United States.

How much did AVM Biotechnology raise?
AVM Biotechnology raised $4.43 Million in a Seed round on May 3, 2021.
What does AVM Biotechnology do?
AVM Biotechnology is dedicated to commercializing AVM0703, a drug designed to combat cancer through activation of the body's immune system.
Where is AVM Biotechnology based and how big is it?
AVM Biotechnology is based in Seattle, Washington, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as AVM Biotechnology that raised within 45 days of this round, from Fundz verified event records.

  • Labviva raised $8M on June 17, 2021.
  • SeLux Diagnostics, Inc. raised $2.5M (Seed) on June 17, 2021.
  • Pinteon Therapeutics, Inc. raised an undisclosed amount (Grant) on June 17, 2021.
  • OncoNano Medicine raised $50M (Series B) on June 17, 2021.
  • DarioHealth raised $24M on June 17, 2021.
  • Korsana Biosciences raised $18M on June 17, 2021.

Who to call at AVM Biotechnology, and when

A new round usually means AVM Biotechnology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AVM Biotechnology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AVM Biotechnology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AVM Biotechnology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AVM Biotechnology

Location

1749 DEXTER AVE N

Seattle, Washington, United States

About

AVM Biotechnology is dedicated to commercializing AVM0703, a drug designed to combat cancer through activation of the body's immune system. The company is conducting Phase 2 clinical trials for its investigational new drug and has a strong patent portfolio. Its leadership team includes experts with extensive experience in drug development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AVM Biotechnology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for AVM Biotechnology's next move

See what Strategic adds

AVM Biotechnology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.